BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $342,000 | -37.8% | 40,700 | -14.6% | 0.01% | -36.4% |
| Q3 2017 | $550,000 | +16.0% | 47,650 | +17.4% | 0.01% | 0.0% |
| Q2 2017 | $474,000 | +7.2% | 40,600 | +13.2% | 0.01% | 0.0% |
| Q1 2017 | $442,000 | -10.0% | 35,850 | -0.6% | 0.01% | 0.0% |
| Q4 2016 | $491,000 | +16266.7% | 36,050 | +16667.4% | 0.01% | – |
| Q3 2015 | $3,000 | -25.0% | 215 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | – | 215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |